The stock of LifeMD Inc (LFMD) has gone down by -6.85% for the week, with a 34.84% rise in the past month and a 19.55% rise in the past quarter. The volatility ratio for the week is 7.90%, and the volatility levels for the past 30 days are 9.50% for LFMD. The simple moving average for the past 20 days is -2.25% for LFMD’s stock, with a -17.20% simple moving average for the past 200 days.
Is It Worth Investing in LifeMD Inc (NASDAQ: LFMD) Right Now?
The 36-month beta value for LFMD is at 1.43. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for LFMD is 34.08M, and currently, shorts hold a 17.22% of that float. The average trading volume for LFMD on December 04, 2024 was 571.82K shares.
LFMD) stock’s latest price update
LifeMD Inc (NASDAQ: LFMD)’s stock price has gone decline by -4.12 in comparison to its previous close of 6.16, however, the company has experienced a -6.85% decrease in its stock price over the last five trading days. https://thefly.com reported 2024-12-03 that Mizuho initiated coverage of LifeMD with a Neutral rating and $7 price target. The firm notes that the company has succeeded due to the successful uptake of its virtual ‘GLP-1 Weight Management’ program, which features access to both branded and compounded GLP-1 drugs for obesity patients, with 80% of the total in compounded. However, investors are grappling with the durability risk of LifeMD’s subscription revenue related to GLP-1 compounding, as if the drugs are taken off the FDA drug shortage list, compounding would no longer be allowed.
Analysts’ Opinion of LFMD
B. Riley Securities, on the other hand, stated in their research note that they expect to see LFMD reach a price target of $11. The rating they have provided for LFMD stocks is “Buy” according to the report published on August 23rd, 2024.
KeyBanc Capital Markets gave a rating of “Overweight” to LFMD, setting the target price at $12 in the report published on June 05th of the current year.
LFMD Trading at 13.89% from the 50-Day Moving Average
After a stumble in the market that brought LFMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.15% of loss for the given period.
Volatility was left at 9.50%, however, over the last 30 days, the volatility rate increased by 7.90%, as shares surge +32.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.05% upper at present.
During the last 5 trading sessions, LFMD fell by -6.78%, which changed the moving average for the period of 200-days by -17.80% in comparison to the 20-day moving average, which settled at $6.04. In addition, LifeMD Inc saw -28.76% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFMD starting from Justin Schreiber, who proposed sale 100,000 shares at the price of $6.60 back on Dec 02 ’24. After this action, Justin Schreiber now owns shares of LifeMD Inc, valued at $660,000 using the latest closing price.
Galluppi Stefan, the Chief Innovation Officer of LifeMD Inc, purchase 3,000 shares at $4.93 during a trade that took place back on Sep 11 ’24, which means that Galluppi Stefan is holding 45,449 shares at $14,790 based on the most recent closing price.
Stock Fundamentals for LFMD
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.92 for the gross margin
The net margin for LifeMD Inc stands at -0.13. The total capital return value is set at -0.87.
Based on LifeMD Inc (LFMD), the company’s capital structure generated 1.73 points at debt to capital in total, while cash flow to debt ratio is standing at 1.19. The debt to equity ratio resting at -2.36. The interest coverage ratio of the stock is -5.39.
Currently, EBITDA for the company is -8.21 million with net debt to EBITDA at 1.19. When we switch over and look at the enterprise to sales, we see a ratio of 1.35. The receivables turnover for the company is 29.74for trailing twelve months and the total asset turnover is 2.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.83.
Conclusion
In conclusion, LifeMD Inc (LFMD) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
